The cold laser therapy market is projected to reach US$ 522.40 million by 2030. Insights based on product, end-user, geography & application.
Instrument Segment Expected to Hold Significant Market Share of Cold Laser Therapy Market During 2022–2030
According to our new research study on " Cold Laser Therapy Market Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis," the market is expected to grow from US$ 322.45 million in 2022 to US$ 522.40 million by 2030; it is anticipated to record a CAGR of 6.2% from 2022 to 2030. The report emphasizes the key factors driving the market and prominent players' developments. Factors such as the rising prevalence of chronic pain conditions such as orthopedic disorders and growing use of cold laser in dermatology propel the cold laser therapy market growth. However, a dearth of skilled professionals with technical expertise and high treatment costs hinders the growth of the market.
Cold laser therapy, also known as low-level laser therapy (LLLT), is a noninvasive and painless treatment to stimulate the healing process by reducing pain and inflammation in the body using low levels of light. During the therapy, different wavelengths of light are directed at the affected body part. The targeted tissue absorbs light at red and near-infrared wavelengths to promote blood circulation and stimulate healing via the regeneration of damaged cells.
Cold Laser Therapy Market, by Geography, 2022 (%)
To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00012143
Source: The Insight Partners Analysis
The development of new and safe laser therapies for clinical indications has led to the growing preference for noninvasive, drug-free treatments such as cold laser therapies for various medical indications. This in turn is anticipated to bring new cold laser therapy market trends in the coming years. According to the American Hip Institute & Orthopedic Specialists, cold laser therapy is a noninvasive and pain-free option that has the potential to decrease the requirement for medication and surgery. Various research studies have been carried out to prove the safety and effectiveness of cold laser therapy in reducing inflammation and pain caused by cancer treatments, orthopedic disorders, and skin diseases. According to an article published by ResearchGate in October 2020, a study was carried out to investigate the efficacy of cold laser therapy to treat brain-related diseases, skin-related diseases, cancers, and bone-related disorders; cold laser therapy was found to be effective in treating these health concerns.
Additionally, the launch of advanced laser technologies by market players for various clinical indications is fueling the cold laser therapy market growth. For instance, in December 2023, Zolar Technologies partnered with Oral Science to launch a new Zolar Photon EXE, a compact and portable diode laser system. This laser system is designed for dental surgical procedures and LLLT applications.
Therefore, the availability of FDA-approved cold laser therapy devices and the growing demand for low-intensity laser therapies among physicians and patients have led to the replacement of traditional high-intensity lasers with advanced cold laser therapy to improve patient outcomes, in turn, promoting the growth of the market.
Bioventus LLC, Lumenis Ltd, BTL Industries Inc, Dynatronics Corporation, Zimmer MedizinSysteme GmbH, Theralase Technologies Inc, Erchonia Corporation, ASA Laser S.p.A., Radiancy Inc, and Biolase Inc are among the key players profiled in the cold laser therapy market report. The companies implement various strategies that contribute to their growth and lead to various changes in the market. The companies utilize organic strategies (such as product launches, expansion, and product approvals) and inorganic strategies (such as collaborations and partnerships) to stay competitive in the market.
A few initiatives taken by key players operating in the global cold laser therapy are listed below
In October 2022, Multi Radiance Medical received FDA clearance for its FibroLux therapeutic laser for pain management in fibromyalgia patients. FibroLux is a handheld, noninvasive laser device with built-in protocols to guide physicians in applying therapy on affected tender points.
In April 2022, Acclaro Corporation introduced UltraClear, a cold fiber laser technology in the US for treating wrinkles, scars, acne scars, pigmentation, enlarged pores, fine lines, and other complexion issues. This medical laser device with MIRACL (i.e., Mid IR Ablative Cold Fiber Laser) technology emits a non-visible laser of 2910 nm wavelength that maximizes tissue ablation and minimizes post-inflammatory hyperpigmentation or post-inflammatory erythema, and bleeding.
The “cold laser therapy market analysis” has been carried out by considering the following segments: product, application, and end user.
Based on product, the market, is carried out into instruments and accessories. The instruments segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. Cold laser devices utilize low-frequency continuous, pulsated or combination lasers with a wavelength of typically 600 to 1000 nm to provide a non-invasive alternative to surgery and acupuncture. It eliminates the complications of long-term drug treatment programs.
The cold laser therapy market, by application, is segmented into orthopedics, dermatology, neurology, and others. The orthopedics segment held a larger cold laser therapy market share in 2022. Orthopedics is expected to hold the largest market share in 2022. During the cold laser therapy, the laser light penetrates the affected tissues and triggers a series of physiological reactions to reduce inflammation, improve blood circulation, and ultimately relieve knee pain. In 2021, guidelines released by the American Academy of Orthopaedic Surgeons (AAOS) included laser therapy for the treatment of pain and inflammation associated with knee osteoarthritis. Further, the dermatology segment is anticipated to register the highest CAGR during 2022–2030.
The market, by end user, is segmented into hospitals, specialty clinics, home care settings, and others. In 2022, the hospital segment held the largest cold laser therapy market share. The specialty clinics segment is anticipated to register the highest CAGR during 2022–2030.
Geographically, the cold laser therapy market report is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In 2022, North America held the largest global market share and is estimated to continue its dominance from 2022 to 2030. The US has a high prevalence of orthopedic diseases and musculoskeletal injuries, which expands the cold laser therapy market size in the region.
Contact Us
Contact Person: Content Team
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.